🔎 Trials Near Me

Utama › Glioma › Florida › Miami

Kajian klinikal Glioma di Miami, FL

15 kajian untuk Glioma sedang mencari peserta di lokasi dalam dan sekitar Miami (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Mengambil pesertaFasa 1/2
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
12 Months – 21 Years · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Mengambil pesertaFasa 2
  • Miami Cancer Institute, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07326566

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Mengambil pesertaFasa 2
  • Nicklaus Children's Hospital, Miami
12 Months – 39 Years · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

Mengambil pesertaKajian pemerhatian
  • University of Miami, Miami
12 Months – 39 Years · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Mengambil pesertaFasa 2
  • University of Miami Hospital and Clinics, Miami
Umur 12 hingga 39 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Mengambil pesertaFasa 3
  • University of Miami Health, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Mengambil pesertaFasa 2
  • Nicklaus Children's Hospital, Miami
Umur 3 hingga 39 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05096481

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Mengambil pesertaFasa 2
  • University of Miami Hospital and Clinics, Miami
Umur 8 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05503797

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Mengambil pesertaFasa 2
  • BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2026 · NCT05188508

STARLITE for Unresectable High-Grade Gliomas

Mengambil pesertaFasa 1
  • University of Miami, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2026 · NCT06428045

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

Mengambil peserta
  • Miami Cancer Institute at Baptist Health, Inc., Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Jun 2026 · NCT06397560

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Mengambil pesertaFasa 2
  • University of Miami Hospital, Miami
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Mei 2026 · NCT06264388

Non-invasive Glioma Characterization Through Molecular Imaging

Mengambil peserta
  • University of Miami, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Apr 2026 · NCT03684109

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Mengambil pesertaFasa 1/2
  • University of Miami, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Mac 2026 · NCT06504381

Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Miami Hospital, Miami
Sehingga umur 18 · Semua jantina · Dikemas kini 20 Nov 2025 · NCT04299191

Kajian Glioma di bandar lain

Kajian lain di Miami

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.